Search results for "nervous system diseases"

showing 10 items of 539 documents

The Sixth Annual Translational Stem Cell Research Conference of the New York Stem Cell Foundation

2012

The New York Stem Cell Foundation's "Sixth Annual Translational Stem Cell Research Conference" convened on October 11-12, 2011 at the Rockefeller University in New York City. Over 450 scientists, patient advocates, and stem cell research supporters from 14 countries registered for the conference. In addition to poster and platform presentations, the conference featured panels entitled "Road to the Clinic" and "The Future of Regenerative Medicine". © 2012 New York Academy of Sciences.

Biochemistry Genetics and Molecular Biology (all)Muscular DiseaseDiabetes MellituHematopoietic Stem CellRegenerative MedicineStem Cell ResearchHeart DiseaseHistory and Philosophy of ScienceDiabetes Mellitus; Heart Diseases; Hematopoietic Stem Cells; Humans; Muscular Diseases; Neoplasms; Nervous System Diseases; Regenerative Medicine; Translational Medical Research; Stem Cell Research; Stem Cell Transplantation; Biochemistry Genetics and Molecular Biology (all); History and Philosophy of ScienceNeoplasmNervous System DiseaseTranslational Medical ResearchHumanStem Cell Transplantation
researchProduct

Automatic bilevel ventilation in sleep-disordered breathing: A real-life experience in southern Italy

2016

Automatic bilevel ventilation (AutoBI) has been recently introduced to treat obstructive sleep-disordered breathing (SDB), but clinical experience is still limited. We revised the charts of patients treated for obstructive SDB in our sleep clinic in 2015 (n=214) to assess the frequency of trials of AutoBI ventilators (ResMed Auto25 or Respironics BiFlex), the clinical characteristics of these patients, the reason to shift from CPAP to AutoBI, and the outcome of AutoBI titration. A trial of domiciliary AutoBI was made in 44 patients (20.5%) intolerant to CPAP due to high CPAP levels (n=11) or who showed incomplete resolution of SDB on CPAP (n=33). The table reports the clinical data accordin…

COPDPediatricsmedicine.medical_specialtyExtreme obesitybusiness.industrymedicine.diseaseAlternative treatmentnervous system diseasesrespiratory tract diseasesBreathingmedicineSleep disordered breathingArterial bloodIn patientbusiness4.2 Sleep and Control of Breathing
researchProduct

Aberrations of Genomic Imprinting in Glioblastoma Formation

2021

In human glioblastoma (GBM), the presence of a small population of cells with stem cell characteristics, the glioma stem cells (GSCs), has been described. These cells have GBM potential and are responsible for the origin of the tumors. However, whether GSCs originate from normal neural stem cells (NSCs) as a consequence of genetic and epigenetic changes and/or dedifferentiation from somatic cells remains to be investigated. Genomic imprinting is an epigenetic marking process that causes genes to be expressed depending on their parental origin. The dysregulation of the imprinting pattern or the loss of genomic imprinting (LOI) have been described in different tumors including GBM, being one …

Cancer ResearchGenomic imprintingSomatic cellSubventricular zonePopulationReviewBiologylcsh:RC254-282MethylationGliomamedicineEpigeneticsImprinting (psychology)educationneural stem cellsNeural stem cellseducation.field_of_studyglioblastomasubventricular zonelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseNeural stem cellgenomic imprintingnervous system diseasesOncologyCancer researchmethylationStem cellGenomic imprintingGlioblastoma
researchProduct

Algorithmically deduced FREM2 molecular pathway is a potent grade and survival biomarker of human gliomas

2021

Gliomas are the most common malignant brain tumors with high mortality rates. Recently we showed that the FREM2 gene has a role in glioblastoma progression. Here we reconstructed the FREM2 molecular pathway using the human interactome model. We assessed the biomarker capacity of FREM2 expression and its pathway as the overall survival (OS) and progression-free survival (PFS) biomarkers. To this end, we used three literature and one experimental RNA sequencing datasets collectively covering 566 glioblastomas (GBM) and 1097 low-grade gliomas (LGG). The activation level of deduced FREM2 pathway showed strong biomarker characteristics and significantly outperformed the FREM2 expression level it…

Cancer ResearchMutantnapoved preživetjaBiologyTranscriptometranscriptomicsGliomagliomagliommedicineGeneRC254-282udc:616-006glioblastomWild typeglioblastomaNeoplasms. Tumors. Oncology. Including cancer and carcinogenssurvival prognosisMolecular pathway<i>FREM2</i>medicine.diseasenervous system diseasesOncologyCancer researchBiomarker (medicine)algorithmically deduced molecular pathwayFREM2Glioblastoma
researchProduct

P08.76 Anti-EGFL7 treatment as an add-on for glioma therapy

2016

Glioblastoma multiforme (GBM) is one the most common and malignant forms of brain tumors. The median survival time of patients diagnosed with primary GBM is around 15 months. In spite of multimodal treatments GBMs remain essentially incurable. Therefore, alternative treatments targeting previously unexplored aspects of GBMs are required. However, the molecular mechanisms underlying the formation of brain tumors have only partially been defined. Especially Notch, a conserved developmental pathway, is promising in terms of GBM formation, as components of this signaling cascade are aberrantly expressed in gliomas. Studies reported that the inhibition of Notch decreased glioma cell proliferatio…

Cancer ResearchText miningOncologybusiness.industryP08 Glioblastom and Anaplastic gliomasGliomaCancer researchMedicineEGFL7Neurology (clinical)businessmedicine.diseasenervous system diseases
researchProduct

Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.

2010

Abstract Meningiomas are often considered benign tumors curable by surgery, but most recurrent meningiomas correspond to histologic benign tumors. Because alterations in chromosome 14 among others have suggested clinical aggressiveness and recurrence, determining both the molecular phenotype and the genetic profile may help distinguish tumors with aggressive metabolism. The aim of this study was to achieve higher specificity in the detection of meningioma subgroups by measuring chromosomal instabilities by fluorescence in situ hybridization and cytogenetics and metabolic phenotypes by high-resolution magic angle spinning spectroscopy. We studied 46 meningioma biopsies with these methodologi…

Cancer Researchmedicine.medical_specialtyPathologyMagnetic Resonance SpectroscopyBiologyMeningiomaChromosomal Instabilityotorhinolaryngologic diseasesmedicineMeningeal NeoplasmsTumor Cells CulturedHumansIn Situ Hybridization FluorescenceNeoplasm StagingChromosome Aberrationsmedicine.diagnostic_testCytogeneticsCancerChromosomemedicine.diseasePhenotypenervous system diseasesOncologyApoptosisBenign MeningiomaCytogenetic AnalysisMetabolomeMeningiomaFluorescence in situ hybridizationCancer research
researchProduct

Cytogenetic analysis and metabolic profiling reveal a subgroup of benign meningiomas with chromosomal instabilities and aggressive metabolism

2010

Meningiomas add up to 30% of Central Nervous System (CNS) tumours. Atypical meningiomas show a high index of recurrence 5 years after complete resection. Sometimes, meningiomas with histological diagnosis of benign meningioma show genetics characteristics of atypical meningioma. Aberrations of chromosomes 1, 14, and 22 are the most frequently reported abnormalities in meningiomas. In this communication we used cytogenetic, FISH, and NMR metabolic profiling for a molecular characterization of a series of 46 meningiomas. Tumor samples were obtained from 46 patients with meningioma (36 benign and 12 atypical) from the Clinic Hospital of Valencia. Cytogenetic analyses were performed by short-te…

Cancer Researchmedicine.medical_specialtyPathologyTissue microarrayKaryotypeBiologymedicine.diseaseBioinformaticsCXCR4nervous system diseasesMeningiomaChromosome instabilityBenign Meningiomaotorhinolaryngologic diseasesGeneticsmedicineHistopathologyRhabdomyosarcomaneoplasmsMolecular BiologyCancer Genetics and Cytogenetics
researchProduct

Health status of young children with cancer following discontinuation of therapy.

1987

This paper reports late effects and health status of 198 children who had cancer or leukemia diagnosed under 2 years of age and their therapies electively withdrawn. This series (92 neuroblastoma (NBL), 57 Wilms' tumor (WT), 46 acute lymphoblastic leukemia (ALL), and 3 non-Hodgkin's lymphoma) was followed for 1-12 years after discontinuation of therapy. Thirty-three children were diagnosed before 1973, 92 between 1973 and 1977, and 73 after 1977 in 16 Italian Pediatric Oncology Centers. As of December 1983, 176 children were reported to be alive and without evidence of primary cancer by physicians responsible for their care. One child died from a second primary tumor, two from late recurren…

Cancer Researchmedicine.medical_specialtyPediatricsmedicine.medical_treatmentAntineoplastic AgentsGrowthNeoplasms Multiple PrimaryLeukoencephalopathyMuscular DiseasesNeoplasmsAcute lymphocytic leukemiamedicineHumansKyphoscoliosisChemotherapyRadiotherapybusiness.industryInfantCancerSequelamedicine.diseaseLeukemia LymphoidDiscontinuationSurgeryRadiation therapyOncologyChild PreschoolPediatrics Perinatology and Child HealthBone DiseasesNeoplasm Recurrence LocalNervous System DiseasesbusinessFollow-Up Studies
researchProduct

Pulmonary haemodynamics in obstructive sleep apnoea.

1995

In patients with obstructive sleep apnoea syndrome (OSAS), pulmonary haemodynamics can show both transient perturbations during sleep and permanent alterations. During sleep, repeated fluctuations in pulmonary artery pressure and pulmonary wedge pressure, coincident with apnoeas, can be observed. Calculation of transmural pressure values is preferable to intravascular pressures in OSAS, due to the marked swings in intrathoracic pressure associated with obstructive apnoeas. Pulmonary artery pressure may progressively increase during sleep, particularly in close sequences of highly desaturating apnoeas. Apnoea-induced hypoxia appears as the most important determinant of this pulmonary artery …

Cardiac outputPulmonary and Respiratory MedicineCardiac outputmedicine.medical_specialtyHypertension PulmonaryVentricular Dysfunction RightCognitive NeuroscienceSleep REMSettore MED/10 - Malattie Dell'Apparato RespiratorioBehavioral Neurosciencestomatognathic systemPhysiology (medical)Internal medicinemedicine.arteryHumansMedicineRespiratory functionWakefulnessHypoxiaPulmonary wedge pressureLungSleep Apnea Obstructivebusiness.industryHemodynamicsSleep apneaGeneral MedicineStroke volumeHypoxia (medical)medicine.diseasePulmonary artery pressurePulmonary hypertensionnervous system diseasesrespiratory tract diseasesObstructive sleep apneaOphthalmologyStroke volumemedicine.anatomical_structureNeurologyObstructive sleep apnoeaVentricleAnesthesiaPulmonary arteryDentistry (all)CardiologyRight ventricleNeurology (clinical)medicine.symptombusinessJournal of sleep research
researchProduct

Altered morphological and electrophysiological properties of Cajal-Retzius cells in cerebral cortex of embryonic Presenilin-1 knockout mice

2004

Mutations of Presenilin-1 are the major cause of familial Alzheimer's disease. Presenilin-1 knockout (PS1-/-) mice develop severe cortical dysplasia related to human type 2 lissencephaly. This overmigration syndrome has been attributed to the premature loss of Cajal-Retzius cells (CRcs), pioneer neurons required for the termination of radial neuronal migration. To elucidate the potential cellular mechanisms responsible for this premature neuronal loss, we investigated the morphological and electrophysiological properties of visually identified CRcs of wild-type (WT) and PS1-/- mouse brains at embryonic day 16.5. The density of CRcs was substantially reduced in the cerebral cortex of PS1-/-.…

Cell Adhesion Molecules NeuronalNerve Tissue ProteinsBiologyBicucullineMembrane PotentialsGABA AntagonistsMicemental disordersExcitatory Amino Acid AgonistsPresenilin-1medicineAnimalsneoplasms6-Cyano-7-nitroquinoxaline-23-dioneCerebral CortexMice KnockoutNeuronsMembrane potentialExtracellular Matrix ProteinsGABAA receptorStem CellsGeneral NeuroscienceSerine EndopeptidasesExcitatory Postsynaptic PotentialsMembrane ProteinsCortical dysplasiaBicucullineEmbryo Mammalianmedicine.diseaseImmunohistochemistryElectric Stimulationdigestive system diseasesnervous system diseasesCell biologyReelin ProteinElectrophysiologymedicine.anatomical_structure2-Amino-5-phosphonovaleratenervous systemCerebral cortexKnockout mouseExcitatory postsynaptic potentialExcitatory Amino Acid AntagonistsNeurosciencemedicine.drugEuropean Journal of Neuroscience
researchProduct